Hiroaki Niiro Selected Research

Fibrosis (Cirrhosis)

1/2022	CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis.
1/2008	Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroaki Niiro Research Topics

Disease

14	Rheumatoid Arthritis 03/2024 - 01/2008
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 01/2008
7	Inflammation (Inflammations) 10/2023 - 02/2010
7	Neoplasms (Cancer) 01/2021 - 07/2007
5	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 02/2004
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2011 - 08/2006
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2023 - 05/2013
4	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 05/2011
4	Vasculitis (Vasculitides) 03/2021 - 05/2013
3	Necrosis 06/2023 - 01/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2015 - 01/2008
2	COVID-19 01/2024 - 06/2023
2	Immunoglobulin G4-Related Disease 12/2023 - 01/2020
2	Severe Acute Respiratory Syndrome 06/2023 - 03/2023
2	Rheumatic Diseases (Rheumatism) 06/2023 - 03/2023
2	Pulmonary Arterial Hypertension 10/2022 - 01/2022
2	Infections 01/2022 - 01/2014
2	Fibrosis (Cirrhosis) 01/2022 - 01/2008
2	Disease Progression 01/2022 - 10/2018
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2021 - 07/2020
2	Giant Cell Arteritis (Horton Disease) 01/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2021 - 07/2016
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2015 - 06/2008
2	Microscopic Polyangiitis 03/2015 - 05/2013
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2015 - 05/2013
2	Lymphoma (Lymphomas) 03/2012 - 02/2009
2	Astrocytoma (Pilocytic Astrocytoma) 08/2008 - 09/2007
2	Glioma (Gliomas) 08/2008 - 07/2007
2	Glioblastoma (Glioblastoma Multiforme) 08/2008 - 09/2007
2	Glomerulonephritis 05/2007 - 12/2005
2	Nephritis 05/2007 - 12/2005
1	Synovitis 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Edema (Dropsy) 01/2023
1	Pericardial Effusion 10/2022
1	Pericarditis 10/2022
1	Bites and Stings (Sting) 03/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Dementia (Dementias) 01/2021

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2021 - 02/2004
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 05/2013
5	Messenger RNA (mRNA)IBA 06/2023 - 07/2007
4	AutoantibodiesIBA 12/2023 - 01/2021
4	Methotrexate (Mexate)FDA LinkGeneric 06/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 03/2012 - 07/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2023 - 01/2021
3	Rituximab (Mabthera)FDA Link 06/2023 - 03/2021
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2023 - 01/2022
3	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 01/2021
3	SteroidsIBA 01/2022 - 01/2020
3	AutoantigensIBA 09/2008 - 08/2006
2	sarilumabIBA 03/2024 - 01/2024
2	AntigensIBA 01/2024 - 01/2021
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 02/2022
2	Interleukin-4 (Interleukin 4)IBA 10/2023 - 02/2004
2	Abatacept (Orencia)FDA Link 06/2023 - 03/2023
2	Tumor Necrosis Factor InhibitorsIBA 06/2023 - 01/2018
2	mizoribineIBA 03/2023 - 01/2022
2	NivolumabIBA 01/2023 - 07/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2013
2	GlucocorticoidsIBA 01/2021 - 07/2020
2	Infliximab (Remicade)FDA Link 01/2021 - 03/2018
2	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2018
2	LigandsIBA 03/2016 - 05/2007
2	ProgranulinsIBA 02/2015 - 11/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 02/2010
1	BNT162 VaccineIBA 01/2024
1	nirmatrelvir and ritonavir drug combinationIBA 01/2024
1	Ritonavir (Norvir)FDA Link 01/2024
1	nirmatrelvirIBA 01/2024
1	AmphiregulinIBA 12/2023
1	Granzymes (Granzyme)IBA 12/2023
1	Small Cytoplasmic RNAIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	Neutralizing AntibodiesIBA 10/2023
1	Immunoglobulin E (IgE)IBA 10/2023
1	mRNA VaccinesIBA 03/2023
1	bucillamine (SA 96)IBA 03/2023
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 03/2023
1	Calcineurin InhibitorsIBA 03/2023
1	Rheumatoid FactorIBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2022
1	InterferonsIBA 03/2022
1	InflammasomesIBA 03/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	selexipagIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Iloprost (Ventavis)FDA Link 01/2022
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2023 - 03/2016
2	Biological Therapy 01/2022 - 02/2010
2	Transplantation 01/2019 - 05/2011
1	Cardiac Catheters 10/2022